Aspergillosis
Research by L. Gil and colleagues in aspergillosis provides new insights
Published in Health Risk Factor Week, March 17th, 2009
"The risk of invasive aspergillosis (IA) is considered to be low among autologous HSCT recipients, but an increase in the incidence has been observed recently in this setting. The aim of the study was to assess the influence of immunosuppressive drugs (steroids, rituximab, fludarabine, thalidomide), used in treatment of lymphoid malignancies during 6 months of pretransplant period, on IA incidence after autologous HSCT," scientists in Poznan, Poland report.
"A total of 109 patients with non-Hodgkin's lymphoma (NHL), Hodgkin's disease (HD) and multiple myeloma (MM), conditioned with carmustine, etoposide, cytarabine, melphalan or melphalan and transplanted with PBSC,...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Health Risk Factor Week
More Articles from Health Risk Factor Week
- Achaogen
Achaogen Signs $26.6 Million Contract With NIAID for Development of New Therapy to Treat Resistant Strains of NIAID Category a and B Priority Pathogens - Aspergillosis Therapy
Research from University of Lille, Institute Pasteur has provided new information about aspergillosis therapy - AutoVirt, Inc
AutoVirt Launches AutoMap - Site Survey Tool - Bacterial Meningitis
Research from J. Gerber and co-researchers provides new data on bacterial meningitis - Bavarian Nordic A/S
Bavarian Nordic Has Essentially Agreed a Pathway for the Licensure of IMVAMUNE With the FDA After Successful End of Phase II Meeting - Bird Flu
Data from A. Gall et al provide new insights into bird flu - More from this issue of Health Risk Factor Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
